shortagewatch

Home / Dermatologicals / Clindamycin

ATC D10AF01 · Antiinfectives for Treatment of Acne · updated 4 Nov 2026

Clindamycin shortage

As of 4 Nov 2026, Clindamycin has a reported shortage in 4 of the 16 countries we track (United States, Canada, Spain, Japan), covering 28 products from 10 companies.

Is there a Clindamycin shortage?

Yes. As of 4 Nov 2026, Clindamycin is reported short in 4 of the 16 countries we track: United States, Canada, Spain, Japan. No company has given a return date.

Countries4/16
Products28packs or presentations
Companies105 listed
Short since9 Nov 20179.0 years ago
Earliest returnnot givencompany estimate
Main reasonNot stated
Free. One email on days with changes. Unsubscribe in one click. Privacy.
United States20 products shortCanada3 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpain1 product shortIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan4 products shortNew ZealandNo reported shortageAustraliaNo reported shortage

How the shortage spread

All cross-border shortages

Countries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 9 Nov 2017; most recently in Japan on 19 Dec 2024.

Not on the official list in: Germany, France, Italy, Ireland, Austria, Belgium, Switzerland, Czechia, Norway, Sweden, New Zealand, Australia.

Timeline

United StatesCanadaSpainJapan
20222023202420252026Clindamycin Phosphate In 5% Dextrose In PlasClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Clindamycin Phosphate In 5% Dextrose In PlasClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Clindamycin Phosphate In 5% Dextrose In PlasClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Clindamycin Phosphate In 5% Dextrose In PlasClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Clindamycin Phosphate In 5% Dextrose In PlasClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Cleocin Phosphate, Injection, Cleocin PhosphCleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Cleocin Phosphate, Injection, Cleocin PhosphCleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Cleocin Phosphate, Injection, Cleocin PhosphCleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Clindamycin Phosphate, Injection, 300 mg/50 Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)Clindamycin Phosphate, Injection, 300 mg/50 Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)Clindamycin Phosphate, Injection, 300 mg/50 Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)Clindamycin Phosphate, Injection, 600 mg/50 Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)Clindamycin Phosphate, Injection, 900 mg/50 Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)Clindamycin Phosphate, Injection, 900 mg/50 Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)Clindamycin Palmitate Hydrochloride, InjectiClindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Clindamycin Palmitate Hydrochloride, InjectiClindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Cleocin Phosphate, Injection, 300 mg/2 mL (1Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)Cleocin Phosphate, Injection, 600 mg/4 mL (1Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26)Cleocin Phosphate, Injection, 600 mg/4 mL (1Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)Cleocin Phosphate, Injection, 900 mg/6 mL (1Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18)CLINDA-T (na)CLINDA-T (na)DALACIN T 1% (30mL)DALACIN T 1% (30mL)DALACIN T 1% (60mL)DALACIN T 1% (60mL)ZINDACLIN 1% GEL, 1 tubo de 30 gZINDACLIN 1% GEL, 1 tubo de 30 gクリンダマイシンリン酸エステルゲル1%「SUN」クリンダマイシンリン酸エステルゲル1%「SUN」クリンダマイシンリン酸エステルゲル1%「クラシエ」クリンダマイシンリン酸エステルゲル1%「クラシエ」クリンダマイシンリン酸エステルゲル1%「サワイ」クリンダマイシンリン酸エステルゲル1%「サワイ」クリンダマイシンリン酸エステルゲル1%「イワキ」クリンダマイシンリン酸エステルゲル1%「イワキ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer9 PFEBaxter6 BAXSandoz5 SDZAmneal2 AMRXValeant Lp1Industrial Cantabria1大興製薬1シオノケミカル1Sawai1 4887岩城製薬1

Listed: Sandoz SDZ · SIX Swiss, Pfizer PFE · NYSE, Baxter BAX · NYSE, Amneal AMRX · Nasdaq, Sawai 4887 · Tokyo

Compared with similar medicines

ATC group D10AF · Antiinfectives for Treatment of Acne
Clindamycin4/16Clindamycin, Combinations3/16Erythromycin1/16Erythromycin, Combinations1/16Nadifloxacin1/16

Affected products

CountryProductCompanySinceExpected backReason
USClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Sandoz Inc.21 Mar 2023not givenNot stated
USClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Sandoz Inc.21 Mar 2023not givenNot stated
USClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Sandoz Inc.21 Mar 2023not givenNot stated
USClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Sandoz Inc.21 Mar 2023not givenNot stated
USClindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Sandoz Inc.21 Mar 2023not givenNot stated
USCleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Pfizer Inc.21 Mar 2023not givenOther
USCleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Pfizer Inc.21 Mar 2023not givenOther
USCleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Pfizer Inc.21 Mar 2023not givenOther
USClindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)Baxter Healthcare21 Mar 2023not givenNot stated
USClindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)Baxter Healthcare21 Mar 2023not givenNot stated
USClindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)Baxter Healthcare21 Mar 2023not givenNot stated
USClindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)Baxter Healthcare21 Mar 2023not givenNot stated
USClindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) limitedBaxter Healthcare21 Mar 2023not givenOther
USClindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)Baxter Healthcare21 Mar 2023not givenNot stated
USClindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) discontinuationAmneal Pharmaceuticals27 Feb 2026not givenNot stated
USClindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19) discontinuationAmneal Pharmaceuticals26 Mar 2026not givenNot stated
USCleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26) discontinuationPfizer Inc.1 Jun 2026not givenNot stated
USCleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26) discontinuationPfizer Inc.1 Jun 2026not givenNot stated
USCleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) discontinuationPfizer Inc.1 Jun 2026not givenNot stated
USCleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) discontinuationPfizer Inc.1 Jun 2026not givenNot stated
CACLINDA-T (na)VALEANT CANADA LP/VALEANT CANADA S.E.C.9 Nov 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CADALACIN T 1% (30mL)PFIZER CANADA INC26 Jan 2018not givenManufacturing problem
Disruption of the manufacture of the drug
CADALACIN T 1% (60mL)PFIZER CANADA INC26 Jan 2018not givenManufacturing problem
Disruption of the manufacture of the drug
ESZINDACLIN 1% GEL, 1 tubo de 30 gIndustrial Farmaceutica Cantabria S.A.28 May 2023not givenNot stated
クリンダマイシンリン酸エステルゲル1%「SUN」 limited大興製薬19 Dec 2024not givenOther
クリンダマイシンリン酸エステルゲル1%「クラシエ」 limitedシオノケミカル19 Dec 2024not givenIncreased demand
クリンダマイシンリン酸エステルゲル1%「サワイ」 limitedSawai4 Jun 2025not givenManufacturing problem
クリンダマイシンリン酸エステルゲル1%「イワキ」 limited岩城製薬7 Nov 2025not givenManufacturing problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Clindamycin shortage?

Yes. As of 4 Nov 2026, Clindamycin is reported short in 4 of the 16 countries we track: United States, Canada, Spain, Japan. No company has given a return date.

When will Clindamycin be back in stock?

No return date has been given; United States: no date given; Canada: no date given; Spain: no date given; Japan: no date given. These are company estimates reported to each authority.

Why is Clindamycin in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Clindamycin shortages?

Pfizer, Baxter, Sandoz, Amneal, Valeant Lp, Industrial Cantabria, 大興製薬, シオノケミカル, Sawai, 岩城製薬.